Dr. Joan M Taylor's lab focuses on understanding the mechanisms behind atherosclerosis, which is a serious cardiovascular disease. The research investigates how smooth muscle cells contribute to plaque formation and stability in blood vessels, as well as the relationships between hypertension and vascular stiffness. By studying specific genetic factors and their effects, the lab aims to develop new treatments to combat hypertension and atherosclerosis, ultimately reducing their impact on public health.

Dr. Li Qian's lab at the University of North Carolina specializes in innovative strategies to repair heart tissue and improve heart function after injuries like heart attacks. By transforming cardiac fibroblasts into functional heart muscle cells using three specific transcription factors, the lab aims to advance therapies for heart failure, a major health issue. Their research combines cutting-edge techniques like single-cell analysis and mathematical modeling to better understand cardiac cell fate and enhance regenerative medicine approaches.

Dr. Matthew J. Flick's lab investigates how blood clots form and how to prevent excessive clotting, which can lead to serious health issues like heart attacks and strokes. The team studies an important protein called fibrinogen, aiming to develop new therapies that reduce the risk of thrombosis while keeping the body’s ability to stop bleeding intact. Their research is crucial for improving public health outcomes related to blood clotting disorders.

Dr. Jiandong Liu's lab at the University of North Carolina Chapel Hill focuses on understanding the cellular dynamics and molecular mechanisms involved in heart regeneration and disease. The lab investigates how different types of cells in the heart, including macrophages and fibroblasts, contribute to heart function and tissue repair. Their research aims to uncover new therapeutic strategies for treating heart diseases by exploring how these cells interact and influence heart cell maturation.

Professor Alain T Laederach's lab focuses on understanding how changes in RNA structure can affect gene expression, particularly in the context of chronic obstructive pulmonary disease (COPD). The research explores the influence of non-coding RNA regions on gene regulation and aims to uncover new targets for RNA-based therapies. By integrating advanced RNA probing technologies and transcriptomics, the lab seeks to shed light on the complexities of RNA structure and its role in disease.

Dr. Daniel Matute's lab focuses on understanding how different species exchange genes and how this impacts evolution. They study hybrid organisms, particularly in the context of the fruit fly Drosophila, to figure out what drives gene exchange and how it influences the creation of new species. By combining fieldwork, genetic analysis, and experimental techniques, the lab aims to unravel the complexities of evolution and its relevance to genetic diversity and human health.

Dr. Mark A. Peifer's lab at the University of North Carolina Chapel Hill focuses on understanding how cells develop and maintain their structure during embryonic development and how these processes can go awry in diseases like cancer. By studying the fruit fly Drosophila and mammalian cells, the team investigates the role of specific proteins and cell signaling pathways in shaping tissues and organs. The research could shed light on fundamental developmental processes and their implications for congenital anomalies and cancer.